| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Skyknight Capital Fund II, L.P. last filed a Form 4 in June 2022, as Director at AHCO.
Our model assigns Skyknight Capital Fund II, L.P. a middling insider score of 53/100, based on 14 past trades. Over a 12-month horizon, 7.1% of those trades were profitable, with an average 12-month return of -31.0%.
At the last filing, the largest reported position was 3,043,056 shares of AHCO. Net of sales, the AHCO filings show accumulation of 616,137 shares.
Skyknight Capital Fund II, L.P. has 9 Form 4 filings on record from March 2022 to June 2022, all as Director at AdaptHealth (AHCO), 2022.
The 15 reported transactions were 15 open-market purchases.
Counted by filing, the open-market trades come to 9 purchases worth about $10.2M and no sales.
The largest open-market purchase was 209,300 shares of AHCO at an average $17.31 on May 24, 2022, about $3.6M. Twelve months later AHCO was down 37%.
Shares as reported in the last Form 4 for each company; the most recent is from June 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2022 | AHCO Adapthealth Corp. | Director | Buy | 100,000 | $17.22 | $1,722,010.00 | +3.4% | +15.2% | -41.0% | |
| Jun 10, 2022 | AHCO Adapthealth Corp. | Director | Buy | 13,922 | $17.44 | $242,756.23 | +0.5% | +5.9% | -42.9% | |
| Jun 1, 2022 | AHCO Adapthealth Corp. | Director | Buy | 35,091 | $17.57 | $616,499.74 | +1.2% | +4.6% | -40.2% | |
| May 25, 2022 | AHCO Adapthealth Corp. | Director | Buy | 200 | $17.50 | $3,500.00 | - | +16.4% | -40.8% | |
| May 24, 2022 | AHCO Adapthealth Corp. | Director | Buy | 209,300 | $17.31 | $3,622,327.59 | +7.8% | +19.5% | -36.9% | |
| May 16, 2022 | AHCO Adapthealth Corp. | Director | Buy | 21,632 | $16.20 | $350,498.97 | +0.8% | +40.4% | -32.9% | |
| May 13, 2022 | AHCO Adapthealth Corp. | Director | Buy | 180,154 | $15.59 | $2,809,119.23 | +7.3% | +42.7% | -34.8% | |
| Mar 14, 2022 | AHCO Adapthealth Corp. | Director | Buy | 42,486 | $15.35 | $652,200.50 | +1.7% | +12.1% | -13.5% | |
| Mar 4, 2022 | AHCO Adapthealth Corp. | Director | Buy | 13,352 | $15.00 | $200,265.31 | +0.6% | +20.4% | +6.0% |